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Patients with Peripheral Vascular Disease: A Meta-Analysis
Ahmed B., Al-Khaffaf H. Eur J Vasc Endovasc Surg 2009;xx:xx-xx.
Objectives: To determine the prevalence of asymptomatic carotid
artery stenosis (ACAS) in patients with peripheral vascular disease (PVD).
Methods: Literature search was carried out through Pubmed, Medline
and Cochrane library. Prospective studies published on prevalence of signif-
icant carotid stenosis in patients with PVD and used a duplex scan for
screenings were included.
Results: Nineteen studies with a total of 4573 patients were
included. A prevalence of 28% (fixed effect model) and 25% (random
effect model) was seen for 50% stenosis, and 14% (in both fixed and
random effect models) for 70% stenosis. Significant statistical heteroge-
neity existed between studies (I2  82.7%, 50% group) (I2  77.5%,
70% group). Larger studies revealed a higher prevalence of carotid
stenosis.
Conclusion: High prevalence of ACAS exists in patients with PVD. A
large multi centre prospective study may help to combat heterogeneity and
identify subgroups of PVD patients with higher prevalence.
Clinicians who believe in the benefits of carotid endarterectomy for
asymptomatic carotid stenosis would gain a greater yield by targeting this
group for routine screening rather than a healthy population.
Prosthetic Carotid Bypass Grafts for Atherosclerotic Lesions: A Pro-
spective Study of 198 Consecutive Cases
Ricco J.B., Marchand C., Neau J.P., Marchand E., Cau J., Fébrer G. Eur J
Vasc Endovasc Surg 2009;xx:xx-xx.
Objectives: Carotid endarterectomy (CEA) is the standard treatment
for atherosclerotic lesions involving the carotid bifurcation. However, CEA
can be challenging under some conditions. The goal of this study was to
determine the outcome and durability of prosthetic carotid bypass grafting
(PCB) with polytetrafluoroethylene (PTFE) grafts as an alternative to CEA.
Methods: This is a prospective series of 198 consecutive patients with
PCB, representing 12.4% of 1595 patients with a carotid reconstruction
procedure performed in our department between September 1986 and
December 2006. Qualifying event was stroke in 67 patients (34%) and
transient ischaemic attack (TIA) in 45 (23%), and 86 patients (43%) were
asymptomatic. Primary indications for PCB were extensive atherosclerotic
lesions (n  71; 36%), carotid stenosis associated with kinking (n  49;
25%), recurrent stenosis (n  47; 23%), stenosis after radiation therapy
(n  18; 9%) and technical failure of CEA (n  13; 7%), with excessive
arterial wall thinning and perforation after endarterectomy (n  10) or
intimal flap on completion digital angiography (n  3).
Results:The combined stroke and death rate at 30 days were 0.5% (one
stroke). Median follow-up was 9.5 years (interquartile range (IQR): 6.2–
18.3 years). At 10 years, primary patency was 97.9  3.4%. Six PCBs (3.0%)
became occluded during follow-up; one patient had a restenosis greater than
50% and 18 patients (9.1%) had a restenosis of less than 50%. Five patients
had an ipsilateral stroke (one postoperative stroke, one at 103 days with a
patent PCB and three related to occlusion of the PCB at 4, 13 and 15 years
after the procedure). At 10 years, cumulative stroke-free survival was
98.4  3.2%, and cumulative survival was 78.8  7.0%.
Conclusions: PCB is a safe surgical alternative and is durable, with a
low incidence of graft restenosis, when CEA seems hazardous.
Urgent Carotid Surgery in Patients with Crescendo Transient Isch-
aemic Attacks and Stroke-in-Evolution: A systematic Review
Karkos C.D., Hernandez-Lahoz I., Naylor A.R. Eur J Vasc Endovasc Surg
2009;xx:xx-xx.
Objective: To document outcomes after urgent carotid surgery in
patients with crescendo transient ischaemic attacks (CTIAs) and stroke-in-
evolution (SIE).
Methods: A systematic review of the English-language literature
using the MEDLINE and EMBASE databases “was undertaken from
January 1984 through December 2007”. Studies reporting the data after
surgery for CTIAs and SIE were identified and stroke, stroke/death and
stroke/death/major cardiac event rates calculated. The studies were
divided into those reporting on CTIAs (group I) and those reporting on
SIE (group II).
814Results: From the databases, 34 relevant series (915 patients) were
retrieved. After excluding those reports on CTIAs, SIE and other ‘urgent’
indications combined together and from which separate data could not be
extracted, a total of 12 series with 176 patients reporting on CTIAs (group I)
and 16 series with 114 patients reporting on SIE (group II) met the inclusion
criteria. All the identified studies were case series of lowmethodological quality
suffering from selection bias. Peri-operative stroke, stroke/death and stroke/
death/major cardiac event rates were 6.5% (95% confidence interval (CI):
3.4–10.4), 9.0% (95% CI: 4.3–15.1) and 10.9% (95% CI: 5.5–17.9), respec-
tively, in group I; and 16.9% (95% CI: 9.2–26.2), 20.0% (95% CI: 12.5–28.6)
and 20.8% (95% CI: 13.2–29.6), respectively, in group II.
Conclusions: The combined risk of neurological and cardiac compli-
cations following urgent carotid surgery for unstable neurological symp-
toms, such as CTIAs and SIE, is higher than that anticipated after elective
surgery for stable symptoms.
Search for Serum Biomarkers Associated with Abdominal Aortic An-
eurysm Growth – A Pilot Study
Vega de Céniga M., Esteban M., Quintana J.M., Barba A., Estallo L., de la
Fuente N., Viviens B., Martin-Ventura J.L. Eur J Vasc Endovasc Surg
2009;xx:xx-xx.
Introduction: Serological biomarkers could reflect asympto-
matic infrarenal aortic aneurysm (AAA) activity and guide patient man-
agement.
Report: Serum concentrations of C-reactive protein (CRP), alpha
1-antitrypsin and lipoprotein(a) were measured in blood samples from 35
AAA patients and 35 controls and correlated with the aortic diameter and
AAA growth in the previous 12 months.
We found a positive correlation between CRP and AAA diameter
(r  0.46; p  0.007) and alpha 1-antitrypsin and AAA growth (r  0.55;
p  0.004).
Conclusions: Alpha 1-antitrypsin may be a promising biomarker of
AAA growth.
Making the Case for Cardiovascular Screening in Irish Males: Detec-
tion of Abdominal Aortic Aneurysms, and Assessment of Cardiovascu-
lar Risk Factors
Brosnan M., Collins C.G., Moneley D.S., Kelly C.J., Leahy A.L. Eur J Vasc
Endovasc Surg 2009;xx:xx-xx.
Introduction: AAA screening programmes have proven to be benefi-
cial and cost effective worldwide for males greater than 65 years of age, with
4.9% males of 65–75 years of age having an un-diagnosed AAA at screening,
resulting in a 42% reduction in the risk of rupture in an English population.
This study assessed the incidence of AAA and risk factors for atherosclerosis
in Irish males of 55–75 years.
Methods: From April 2006 to December 2007, males between the
ages of 55 and 75 years, living within the catchment area of Blanchardstown
Hospital were invited for AAA screening using duplex ultrasound and
cardiovascular risk factor screening.
Results: 1.9% (17/904) of the study population had previously un-
diagnosed aneurysms detected, with sizes ranging from 3.0 cm to 5.8 cm
(0.6% in 55–65 years old (yo) and 4.2% in 65–75 yo, p  0.01). 33%
(302/904) of patients had hyperlipidaemia, while 16% of those with a
previous diagnosis of hyperlipidaemia, were inadequately controlled on the
test date. 31% of patients had a single elevated blood pressure reading,
meriting further investigation for possible hypertension. 3% (28/904) of all
patients had a raised glucose levels which had not previously been identified
and of those who had a previous history of DM, 46% had abnormal glucose
levels. 16% of patients (93/573) were morbidly obese (BMI  30) and 64%
(292/573) were overweight.
Conclusion: The incidence of AAAs in 65–75-year-old men is similar
to international figures. This study confirms that screening for hyperlipidae-
mia, hypercholesterolaemia, obesity and hypertension may be worthwhile in
all males over 55 years, while AAA screening should be reserved for 65–75-
year-old Irish males.
